In response to your last paragraph - have you considered that...

In response to your last paragraph - have you considered that SPL are not primarily concerned with day to day marketing or sellng of this product?

Sure whoever they licence the distribution to should be doing a better job. But the products were developed as proof of a saleable dendrimer product. All along, SPL have said that they may sell off this entire arm of the business, or in fact once the Dep oncology advances further, perhsps split SPL into different businesses on the asx or to be sold off as completely separate businesses.

We haven't heard mention of this idea for a while either, but I would think it still entirely plausible that this could still come into play.

Thoughts?